Malcolm S. Mitchell
- Immunology top 2%
- Immunotherapy and Immune Responses 41
- Immune Cell Function and Interaction 19
- T-cell and B-cell Immunology 19
- Immune Response and Inflammation 7
- Oncology top 5%
- CAR-T cell therapy research 10
- Cancer Immunotherapy and Biomarkers 10
-
- Monoclonal and Polyclonal Antibodies Research 16
- Biotechnology top 5%
- Molecular Biology top 10%
- Glycosylation and Glycoproteins Research 6
- Co-authors
- June Kan‐MitchellMargalit B. MokyrRaymond A. KempfVicky JonesHerbert F. OettgenRonald C. DeContiRichard K. GershonMichael L.J. Apuzzo
- Journals
- Cancer Immunology Immunotherapy (8 papers)Cancer (6 papers)Journal of Clinical Oncology (6 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Malcolm S. Mitchell
103 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 111
- Immunology 1.3k
- Oncology 960
- Radiology, Nuclear Medicine and Imaging 387
- Biotechnology 113
- Molecular Biology 738
Countries citing papers authored by Malcolm S. Mitchell
This map shows the geographic impact of Malcolm S. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm S. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm S. Mitchell more than expected).
Fields of papers citing papers by Malcolm S. Mitchell
This network shows the impact of papers produced by Malcolm S. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm S. Mitchell. The network helps show where Malcolm S. Mitchell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Malcolm S. Mitchell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 14 | |
| 2 | 2004 | 26 | |
| 3 | 2003 | 63 | |
| 4 | A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes. | 2000 | 32 |
| 5 | 1999 | 22 | |
| 6 | 1998 | 108 | |
| 7 | 1996 | 14 | |
| 8 | 1996 | 8 | |
| 9 | 1993 | 79 | |
| 10 | 1992 | 8 | |
| 11 | 1990 | 2 | |
| 12 | 1989 | 3 | |
| 13 | Human tumor antigens and specific tumor therapy : proceedings of a Cetus-Triton Biosciences-UCLA Symposium held at Keystone, Colorado, April 23-30, 1988 | 1989 | 1 |
| 14 | 1988 | 11 | |
| 15 | The Modulation of immunity | 1985 | 7 |
| 16 | 1976 | 4 | |
| 17 | 1975 | 39 | |
| 18 | 1975 | 7 | |
| 19 | 1973 | 24 | |
| 20 | 1965 | 3 |
About Malcolm S. Mitchell
Malcolm S. Mitchell is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Hematology and Microbiology, having authored 103 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (41 papers), Immune Cell Function and Interaction (19 papers), T-cell and B-cell Immunology (19 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), CAR-T cell therapy research (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Immune Response and Inflammation (7 papers) and Glycosylation and Glycoproteins Research (6 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (960 citations), Radiology, Nuclear Medicine and Imaging (387 citations), Biotechnology (113 citations) and Molecular Biology (738 citations). Malcolm S. Mitchell has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include June Kan‐Mitchell, Margalit B. Mokyr, Raymond A. Kempf, Vicky Jones, Herbert F. Oettgen, Ronald C. DeConti, Richard K. Gershon, Michael L.J. Apuzzo, Robert G. Peterson and Robert E. Handschumacher. Their work appears in journals such as Cancer Immunology Immunotherapy, Cancer, Journal of Clinical Oncology, Cancer Investigation and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.